Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects

Reseda odorata L. has long been used in traditional Asian medicine for the treatment of diseases associated with oxidative injury and acute inflammation, such as endotoxemia, acute lung injury, acute myocardial infarction and hepatitis. Luteolin, the main component of Reseda odorata L., which is als...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular medicine 2017-01, Vol.39 (1), p.113-125
Hauptverfasser: Xiong, Jie, Wang, Kezhou, Yuan, Chunxiao, Xing, Rong, Ni, Jianbo, Hu, Guoyong, Chen, Fengling, Wang, Xingpeng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 125
container_issue 1
container_start_page 113
container_title International journal of molecular medicine
container_volume 39
creator Xiong, Jie
Wang, Kezhou
Yuan, Chunxiao
Xing, Rong
Ni, Jianbo
Hu, Guoyong
Chen, Fengling
Wang, Xingpeng
description Reseda odorata L. has long been used in traditional Asian medicine for the treatment of diseases associated with oxidative injury and acute inflammation, such as endotoxemia, acute lung injury, acute myocardial infarction and hepatitis. Luteolin, the main component of Reseda odorata L., which is also widely found in many natural herbs and vege tables, has been shown to induce heme oxygenase-1 (HO-1) expression to exert anti-inflammatory and antioxidant effects. In this study, we aimed to examine the effects of luteolin on mice with severe acute pancreatitis (SAP), and to explore the underlying mechanisms. Cerulein and lipopolysaccharide were used to induce SAP in male Institute of Cancer Research (ICR) mice in the SAP group. The SAP group was divided into 4 subgroups, as follows: the vehicle, luteolin, zinc protoporphyrin (ZnPP) only, and luteolin (Lut) + ZnPP (luteolin plus zinc protoporphyrin treatment) groups. The wet/dry weight ratios, hematoxylin and eosin staining and pathological scores of pancreatic tissues were assessed and compared to those of the control mice. Amylase, lipase, nuclear factor-κB (NF-κB) and myeloperoxidase activities, and malondialdehyde, tumor necrosis factor α (TNFα), interleukin (IL)-6, IL-10 and HO-1 levels, as well as the expression of HO-1 were determined in serum and/or pancreatic tissue samples. SAP was successfully induced in male mice compared to normal control mice. The wet/dry weight ratios, pathological scores, and amylase and lipase activity, as well as the levels of TNFα and IL-6 were significantly reduced in the pancreatic tissues of the mice in the Lut group compared with those of the mice in the vehicle group. The Lut group exhibited a significant increase in HO-1 expression in the pancreas and enhanced serum HO-1 and IL-10 levels compared with the vehicle group. The suppression of HO-1 activity in the ZnPP group significantly abolished the protective effects of luteolin. NF-κB expression in the pancreatic tissues from the mice in the Lut + ZnPP group was significantly increased following the suppression of HO-1 activity. On the whole, our findings demonstrate that luteolin protects mice from SAP by inducing HO-1-mediated anti-inflammatory and antioxidant activities, in association with the suppression of the activation of the NF-κB pathway.
doi_str_mv 10.3892/ijmm.2016.2809
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5179180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A479624851</galeid><sourcerecordid>A479624851</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-fbba0e170eef3ecc067961a8be56dfcbcfb4cc13a2653c26afaf04f6bf74dca43</originalsourceid><addsrcrecordid>eNptUs9rFDEUHkSxtXr1KAEvXrLm1ySZi1BKtcJCLwreQibzsmaZmaxJtnT_-2bYdlUoCbzw8r0vX977muY9JSuuO_Y5bKdpxQiVK6ZJ96I5p6qjmAnx62U9U6IwV608a97kvCWEtaLTr5szprTSTMjz5rDeF4hjmNEuxQKuZDQFB8inOKEMd5AAWVcxaGdnl8CWUEJG_QHBPaQS5g26ucUUTzAEW2BAdi4Bh9mPdppsielQM8dsvA9DjQi8X95527zydszw7jFeND-_Xv-4usHr22_fry7X2AmhC_Z9bwlQRQA8B-eIVJ2kVvfQysG73vleOEe5ZbLljknrrSfCy94rMTgr-EXz5ci72_dVpYO5JDuaXQqTTQcTbTD_38zht9nEO9MurdSkEnx8JEjxzx5yMdu4T3PVbGjHqeIdEfwvamNHMLUBsZK5KWRnLkWVzIRuaUWtnkHVNUBte5zBh5p_rsClmHMCfxJOiVkcYBYHmMUBZnFALfjw73dP8KeRV8CnIyDXiQ5hiPmEWagw7zChdVPOHwC3hL4L</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1931739043</pqid></control><display><type>article</type><title>Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects</title><source>Spandidos Publications Journals</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Xiong, Jie ; Wang, Kezhou ; Yuan, Chunxiao ; Xing, Rong ; Ni, Jianbo ; Hu, Guoyong ; Chen, Fengling ; Wang, Xingpeng</creator><creatorcontrib>Xiong, Jie ; Wang, Kezhou ; Yuan, Chunxiao ; Xing, Rong ; Ni, Jianbo ; Hu, Guoyong ; Chen, Fengling ; Wang, Xingpeng</creatorcontrib><description>Reseda odorata L. has long been used in traditional Asian medicine for the treatment of diseases associated with oxidative injury and acute inflammation, such as endotoxemia, acute lung injury, acute myocardial infarction and hepatitis. Luteolin, the main component of Reseda odorata L., which is also widely found in many natural herbs and vege tables, has been shown to induce heme oxygenase-1 (HO-1) expression to exert anti-inflammatory and antioxidant effects. In this study, we aimed to examine the effects of luteolin on mice with severe acute pancreatitis (SAP), and to explore the underlying mechanisms. Cerulein and lipopolysaccharide were used to induce SAP in male Institute of Cancer Research (ICR) mice in the SAP group. The SAP group was divided into 4 subgroups, as follows: the vehicle, luteolin, zinc protoporphyrin (ZnPP) only, and luteolin (Lut) + ZnPP (luteolin plus zinc protoporphyrin treatment) groups. The wet/dry weight ratios, hematoxylin and eosin staining and pathological scores of pancreatic tissues were assessed and compared to those of the control mice. Amylase, lipase, nuclear factor-κB (NF-κB) and myeloperoxidase activities, and malondialdehyde, tumor necrosis factor α (TNFα), interleukin (IL)-6, IL-10 and HO-1 levels, as well as the expression of HO-1 were determined in serum and/or pancreatic tissue samples. SAP was successfully induced in male mice compared to normal control mice. The wet/dry weight ratios, pathological scores, and amylase and lipase activity, as well as the levels of TNFα and IL-6 were significantly reduced in the pancreatic tissues of the mice in the Lut group compared with those of the mice in the vehicle group. The Lut group exhibited a significant increase in HO-1 expression in the pancreas and enhanced serum HO-1 and IL-10 levels compared with the vehicle group. The suppression of HO-1 activity in the ZnPP group significantly abolished the protective effects of luteolin. NF-κB expression in the pancreatic tissues from the mice in the Lut + ZnPP group was significantly increased following the suppression of HO-1 activity. On the whole, our findings demonstrate that luteolin protects mice from SAP by inducing HO-1-mediated anti-inflammatory and antioxidant activities, in association with the suppression of the activation of the NF-κB pathway.</description><identifier>ISSN: 1107-3756</identifier><identifier>EISSN: 1791-244X</identifier><identifier>DOI: 10.3892/ijmm.2016.2809</identifier><identifier>PMID: 27878246</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Acute Disease ; Analysis ; Animals ; Anti-Inflammatory Agents - pharmacology ; Anti-Inflammatory Agents - therapeutic use ; Anti-inflammatory drugs ; Antioxidants ; Antioxidants - pharmacology ; Antioxidants - therapeutic use ; Care and treatment ; Ceruletide ; Chromatography, High Pressure Liquid ; Cytokines ; Cytokines - blood ; Cytokines - metabolism ; heme oxygenase-1 ; Heme Oxygenase-1 - blood ; Heme Oxygenase-1 - metabolism ; Inflammation Mediators - metabolism ; Inflammatory diseases ; interleukin-10 ; Laboratory animals ; Lipopolysaccharides ; luteolin ; Luteolin - pharmacology ; Luteolin - therapeutic use ; Male ; Mice, Inbred ICR ; Models, Biological ; Multiple organ dysfunction syndrome ; Necrosis ; NF-kappa B - metabolism ; Nitric oxide ; nuclear factor-κB ; Oxidative stress ; Pancreas - drug effects ; Pancreas - enzymology ; Pancreas - pathology ; Pancreatitis ; Pancreatitis - blood ; Pancreatitis - drug therapy ; Pancreatitis - enzymology ; Protective Agents - pharmacology ; Protective Agents - therapeutic use ; Protoporphyrins - pharmacology ; Protoporphyrins - therapeutic use ; Risk factors ; Rodents ; severe acute pancreatitis ; Studies</subject><ispartof>International journal of molecular medicine, 2017-01, Vol.39 (1), p.113-125</ispartof><rights>Copyright: © Xiong et al.</rights><rights>COPYRIGHT 2017 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2017</rights><rights>Copyright: © Xiong et al. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-fbba0e170eef3ecc067961a8be56dfcbcfb4cc13a2653c26afaf04f6bf74dca43</citedby><cites>FETCH-LOGICAL-c448t-fbba0e170eef3ecc067961a8be56dfcbcfb4cc13a2653c26afaf04f6bf74dca43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,5571,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27878246$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xiong, Jie</creatorcontrib><creatorcontrib>Wang, Kezhou</creatorcontrib><creatorcontrib>Yuan, Chunxiao</creatorcontrib><creatorcontrib>Xing, Rong</creatorcontrib><creatorcontrib>Ni, Jianbo</creatorcontrib><creatorcontrib>Hu, Guoyong</creatorcontrib><creatorcontrib>Chen, Fengling</creatorcontrib><creatorcontrib>Wang, Xingpeng</creatorcontrib><title>Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects</title><title>International journal of molecular medicine</title><addtitle>Int J Mol Med</addtitle><description>Reseda odorata L. has long been used in traditional Asian medicine for the treatment of diseases associated with oxidative injury and acute inflammation, such as endotoxemia, acute lung injury, acute myocardial infarction and hepatitis. Luteolin, the main component of Reseda odorata L., which is also widely found in many natural herbs and vege tables, has been shown to induce heme oxygenase-1 (HO-1) expression to exert anti-inflammatory and antioxidant effects. In this study, we aimed to examine the effects of luteolin on mice with severe acute pancreatitis (SAP), and to explore the underlying mechanisms. Cerulein and lipopolysaccharide were used to induce SAP in male Institute of Cancer Research (ICR) mice in the SAP group. The SAP group was divided into 4 subgroups, as follows: the vehicle, luteolin, zinc protoporphyrin (ZnPP) only, and luteolin (Lut) + ZnPP (luteolin plus zinc protoporphyrin treatment) groups. The wet/dry weight ratios, hematoxylin and eosin staining and pathological scores of pancreatic tissues were assessed and compared to those of the control mice. Amylase, lipase, nuclear factor-κB (NF-κB) and myeloperoxidase activities, and malondialdehyde, tumor necrosis factor α (TNFα), interleukin (IL)-6, IL-10 and HO-1 levels, as well as the expression of HO-1 were determined in serum and/or pancreatic tissue samples. SAP was successfully induced in male mice compared to normal control mice. The wet/dry weight ratios, pathological scores, and amylase and lipase activity, as well as the levels of TNFα and IL-6 were significantly reduced in the pancreatic tissues of the mice in the Lut group compared with those of the mice in the vehicle group. The Lut group exhibited a significant increase in HO-1 expression in the pancreas and enhanced serum HO-1 and IL-10 levels compared with the vehicle group. The suppression of HO-1 activity in the ZnPP group significantly abolished the protective effects of luteolin. NF-κB expression in the pancreatic tissues from the mice in the Lut + ZnPP group was significantly increased following the suppression of HO-1 activity. On the whole, our findings demonstrate that luteolin protects mice from SAP by inducing HO-1-mediated anti-inflammatory and antioxidant activities, in association with the suppression of the activation of the NF-κB pathway.</description><subject>Acute Disease</subject><subject>Analysis</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents - pharmacology</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Anti-inflammatory drugs</subject><subject>Antioxidants</subject><subject>Antioxidants - pharmacology</subject><subject>Antioxidants - therapeutic use</subject><subject>Care and treatment</subject><subject>Ceruletide</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cytokines</subject><subject>Cytokines - blood</subject><subject>Cytokines - metabolism</subject><subject>heme oxygenase-1</subject><subject>Heme Oxygenase-1 - blood</subject><subject>Heme Oxygenase-1 - metabolism</subject><subject>Inflammation Mediators - metabolism</subject><subject>Inflammatory diseases</subject><subject>interleukin-10</subject><subject>Laboratory animals</subject><subject>Lipopolysaccharides</subject><subject>luteolin</subject><subject>Luteolin - pharmacology</subject><subject>Luteolin - therapeutic use</subject><subject>Male</subject><subject>Mice, Inbred ICR</subject><subject>Models, Biological</subject><subject>Multiple organ dysfunction syndrome</subject><subject>Necrosis</subject><subject>NF-kappa B - metabolism</subject><subject>Nitric oxide</subject><subject>nuclear factor-κB</subject><subject>Oxidative stress</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - enzymology</subject><subject>Pancreas - pathology</subject><subject>Pancreatitis</subject><subject>Pancreatitis - blood</subject><subject>Pancreatitis - drug therapy</subject><subject>Pancreatitis - enzymology</subject><subject>Protective Agents - pharmacology</subject><subject>Protective Agents - therapeutic use</subject><subject>Protoporphyrins - pharmacology</subject><subject>Protoporphyrins - therapeutic use</subject><subject>Risk factors</subject><subject>Rodents</subject><subject>severe acute pancreatitis</subject><subject>Studies</subject><issn>1107-3756</issn><issn>1791-244X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptUs9rFDEUHkSxtXr1KAEvXrLm1ySZi1BKtcJCLwreQibzsmaZmaxJtnT_-2bYdlUoCbzw8r0vX977muY9JSuuO_Y5bKdpxQiVK6ZJ96I5p6qjmAnx62U9U6IwV608a97kvCWEtaLTr5szprTSTMjz5rDeF4hjmNEuxQKuZDQFB8inOKEMd5AAWVcxaGdnl8CWUEJG_QHBPaQS5g26ucUUTzAEW2BAdi4Bh9mPdppsielQM8dsvA9DjQi8X95527zydszw7jFeND-_Xv-4usHr22_fry7X2AmhC_Z9bwlQRQA8B-eIVJ2kVvfQysG73vleOEe5ZbLljknrrSfCy94rMTgr-EXz5ci72_dVpYO5JDuaXQqTTQcTbTD_38zht9nEO9MurdSkEnx8JEjxzx5yMdu4T3PVbGjHqeIdEfwvamNHMLUBsZK5KWRnLkWVzIRuaUWtnkHVNUBte5zBh5p_rsClmHMCfxJOiVkcYBYHmMUBZnFALfjw73dP8KeRV8CnIyDXiQ5hiPmEWagw7zChdVPOHwC3hL4L</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Xiong, Jie</creator><creator>Wang, Kezhou</creator><creator>Yuan, Chunxiao</creator><creator>Xing, Rong</creator><creator>Ni, Jianbo</creator><creator>Hu, Guoyong</creator><creator>Chen, Fengling</creator><creator>Wang, Xingpeng</creator><general>D.A. Spandidos</general><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects</title><author>Xiong, Jie ; Wang, Kezhou ; Yuan, Chunxiao ; Xing, Rong ; Ni, Jianbo ; Hu, Guoyong ; Chen, Fengling ; Wang, Xingpeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-fbba0e170eef3ecc067961a8be56dfcbcfb4cc13a2653c26afaf04f6bf74dca43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acute Disease</topic><topic>Analysis</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents - pharmacology</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Anti-inflammatory drugs</topic><topic>Antioxidants</topic><topic>Antioxidants - pharmacology</topic><topic>Antioxidants - therapeutic use</topic><topic>Care and treatment</topic><topic>Ceruletide</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cytokines</topic><topic>Cytokines - blood</topic><topic>Cytokines - metabolism</topic><topic>heme oxygenase-1</topic><topic>Heme Oxygenase-1 - blood</topic><topic>Heme Oxygenase-1 - metabolism</topic><topic>Inflammation Mediators - metabolism</topic><topic>Inflammatory diseases</topic><topic>interleukin-10</topic><topic>Laboratory animals</topic><topic>Lipopolysaccharides</topic><topic>luteolin</topic><topic>Luteolin - pharmacology</topic><topic>Luteolin - therapeutic use</topic><topic>Male</topic><topic>Mice, Inbred ICR</topic><topic>Models, Biological</topic><topic>Multiple organ dysfunction syndrome</topic><topic>Necrosis</topic><topic>NF-kappa B - metabolism</topic><topic>Nitric oxide</topic><topic>nuclear factor-κB</topic><topic>Oxidative stress</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - enzymology</topic><topic>Pancreas - pathology</topic><topic>Pancreatitis</topic><topic>Pancreatitis - blood</topic><topic>Pancreatitis - drug therapy</topic><topic>Pancreatitis - enzymology</topic><topic>Protective Agents - pharmacology</topic><topic>Protective Agents - therapeutic use</topic><topic>Protoporphyrins - pharmacology</topic><topic>Protoporphyrins - therapeutic use</topic><topic>Risk factors</topic><topic>Rodents</topic><topic>severe acute pancreatitis</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xiong, Jie</creatorcontrib><creatorcontrib>Wang, Kezhou</creatorcontrib><creatorcontrib>Yuan, Chunxiao</creatorcontrib><creatorcontrib>Xing, Rong</creatorcontrib><creatorcontrib>Ni, Jianbo</creatorcontrib><creatorcontrib>Hu, Guoyong</creatorcontrib><creatorcontrib>Chen, Fengling</creatorcontrib><creatorcontrib>Wang, Xingpeng</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xiong, Jie</au><au>Wang, Kezhou</au><au>Yuan, Chunxiao</au><au>Xing, Rong</au><au>Ni, Jianbo</au><au>Hu, Guoyong</au><au>Chen, Fengling</au><au>Wang, Xingpeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects</atitle><jtitle>International journal of molecular medicine</jtitle><addtitle>Int J Mol Med</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>39</volume><issue>1</issue><spage>113</spage><epage>125</epage><pages>113-125</pages><issn>1107-3756</issn><eissn>1791-244X</eissn><abstract>Reseda odorata L. has long been used in traditional Asian medicine for the treatment of diseases associated with oxidative injury and acute inflammation, such as endotoxemia, acute lung injury, acute myocardial infarction and hepatitis. Luteolin, the main component of Reseda odorata L., which is also widely found in many natural herbs and vege tables, has been shown to induce heme oxygenase-1 (HO-1) expression to exert anti-inflammatory and antioxidant effects. In this study, we aimed to examine the effects of luteolin on mice with severe acute pancreatitis (SAP), and to explore the underlying mechanisms. Cerulein and lipopolysaccharide were used to induce SAP in male Institute of Cancer Research (ICR) mice in the SAP group. The SAP group was divided into 4 subgroups, as follows: the vehicle, luteolin, zinc protoporphyrin (ZnPP) only, and luteolin (Lut) + ZnPP (luteolin plus zinc protoporphyrin treatment) groups. The wet/dry weight ratios, hematoxylin and eosin staining and pathological scores of pancreatic tissues were assessed and compared to those of the control mice. Amylase, lipase, nuclear factor-κB (NF-κB) and myeloperoxidase activities, and malondialdehyde, tumor necrosis factor α (TNFα), interleukin (IL)-6, IL-10 and HO-1 levels, as well as the expression of HO-1 were determined in serum and/or pancreatic tissue samples. SAP was successfully induced in male mice compared to normal control mice. The wet/dry weight ratios, pathological scores, and amylase and lipase activity, as well as the levels of TNFα and IL-6 were significantly reduced in the pancreatic tissues of the mice in the Lut group compared with those of the mice in the vehicle group. The Lut group exhibited a significant increase in HO-1 expression in the pancreas and enhanced serum HO-1 and IL-10 levels compared with the vehicle group. The suppression of HO-1 activity in the ZnPP group significantly abolished the protective effects of luteolin. NF-κB expression in the pancreatic tissues from the mice in the Lut + ZnPP group was significantly increased following the suppression of HO-1 activity. On the whole, our findings demonstrate that luteolin protects mice from SAP by inducing HO-1-mediated anti-inflammatory and antioxidant activities, in association with the suppression of the activation of the NF-κB pathway.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>27878246</pmid><doi>10.3892/ijmm.2016.2809</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1107-3756
ispartof International journal of molecular medicine, 2017-01, Vol.39 (1), p.113-125
issn 1107-3756
1791-244X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5179180
source Spandidos Publications Journals; MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Acute Disease
Analysis
Animals
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Anti-inflammatory drugs
Antioxidants
Antioxidants - pharmacology
Antioxidants - therapeutic use
Care and treatment
Ceruletide
Chromatography, High Pressure Liquid
Cytokines
Cytokines - blood
Cytokines - metabolism
heme oxygenase-1
Heme Oxygenase-1 - blood
Heme Oxygenase-1 - metabolism
Inflammation Mediators - metabolism
Inflammatory diseases
interleukin-10
Laboratory animals
Lipopolysaccharides
luteolin
Luteolin - pharmacology
Luteolin - therapeutic use
Male
Mice, Inbred ICR
Models, Biological
Multiple organ dysfunction syndrome
Necrosis
NF-kappa B - metabolism
Nitric oxide
nuclear factor-κB
Oxidative stress
Pancreas - drug effects
Pancreas - enzymology
Pancreas - pathology
Pancreatitis
Pancreatitis - blood
Pancreatitis - drug therapy
Pancreatitis - enzymology
Protective Agents - pharmacology
Protective Agents - therapeutic use
Protoporphyrins - pharmacology
Protoporphyrins - therapeutic use
Risk factors
Rodents
severe acute pancreatitis
Studies
title Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T14%3A06%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Luteolin%20protects%20mice%20from%20severe%20acute%20pancreatitis%20by%20exerting%20HO-1-mediated%20anti-inflammatory%20and%20antioxidant%20effects&rft.jtitle=International%20journal%20of%20molecular%20medicine&rft.au=Xiong,%20Jie&rft.date=2017-01-01&rft.volume=39&rft.issue=1&rft.spage=113&rft.epage=125&rft.pages=113-125&rft.issn=1107-3756&rft.eissn=1791-244X&rft_id=info:doi/10.3892/ijmm.2016.2809&rft_dat=%3Cgale_pubme%3EA479624851%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1931739043&rft_id=info:pmid/27878246&rft_galeid=A479624851&rfr_iscdi=true